Biochemie und Chemie
Refine
Year of publication
- 2016 (81) (remove)
Document Type
- Article (46)
- Doctoral Thesis (25)
- Book (6)
- Contribution to a Periodical (3)
- Other (1)
Has Fulltext
- yes (81)
Is part of the Bibliography
- no (81)
Keywords
- crystal structure (7)
- Atomic force microscopy (2)
- Brownian dynamics simulation (2)
- Membrane proteins (2)
- Molecular dynamics simulation (2)
- Nanoscale biophysics (2)
- Single molecule force spectroscopy (2)
- Super-resolution microscopy (2)
- hydrogen bonding (2)
- von Willebrand factor (2)
- 1,3-diazinane (1)
- 5-lipoxygenase (1)
- Acylimin Sulfonylimin (1)
- BET inhibitors (1)
- Bacterial genomics (1)
- Biophysical chemistry (1)
- Biopolymers in vivo (1)
- C-H...O interactions (1)
- Cell biology (1)
- Computational models (1)
- Conformational Dynamics (1)
- Cryoelectron microscopy (1)
- Cytological techniques (1)
- C—H⋯Br and C—H⋯O hydrogen bonds (1)
- DNA damage (1)
- Data processing (1)
- Density Functional Theory (1)
- Dimethyl maleic anhydride (1)
- E. coli (1)
- EIGER detector (1)
- Enzymes and Biomimetic Systems (1)
- FF-ATP synthase dimer (1)
- Fettsäuresynthase (1)
- G protein-coupled receptor (GPCR) (1)
- H3 receptor (1)
- Hydroxylation (1)
- Kinases (1)
- LILBID-MS (1)
- Mass spectrometry (1)
- Membrane biophysics (1)
- Membrane protein complex (1)
- Methanogenesis (1)
- Multikomponentenreaktion (1)
- N5 -methyl-tetrahydromethanopterin: coenzyme M methyltransferase (1)
- NF-kappaB (1)
- NMR crystallography (1)
- Nascent RNA (1)
- Oligonukleotide (1)
- Optical Spectroscopy (1)
- Optical tweezers (1)
- PABP (1)
- Palladium-Katalyse (1)
- Photodynamics (1)
- Primary hemostasis (1)
- RNA in zebrafish brain (1)
- RNA recognition motif (1)
- RNA sequencing (RNA-Seq) (1)
- Ribonucleic Acids (1)
- Ribosome (1)
- SEC-MALS (1)
- SF3b145 (1)
- SF3b49 (1)
- Schiff bases (1)
- Single-particle (1)
- Sinorhizobium fredii (1)
- Solution-state NMR (1)
- Ste2p (1)
- TATU (1)
- Time-resolved Fluorescence (1)
- Topology (1)
- Transition Metals (1)
- Transporters (1)
- U2 snRNP (1)
- X-ray crystallography (1)
- X-ray detectors (1)
- X-ray diffraction (1)
- Y10B (1)
- Zweiphotonen (1)
- absolute configuration (1)
- anthrone (1)
- antibiotic resistance (1)
- anticonvulsant activity (1)
- automatic environmental tobacco smoke emitter (1)
- bacterial resistance mechanisms (1)
- benzoxazine (1)
- benzoxazines (1)
- bioenergetics (1)
- biophysics (1)
- bromodomain (1)
- cell biology (1)
- chlorosilane (1)
- co-crystalline adducts (1)
- cryo-EM (1)
- cryoEM (1)
- cryoelectron microscopy (1)
- cycloaddition (1)
- cytotoxicity (1)
- data-collection strategy (1)
- density functional calculations (1)
- designed multitarget ligands (1)
- efflux pumps (1)
- electron cryomicroscopy (1)
- electron tomography (1)
- enantioselektive Synthese (1)
- environmental tobacco smoke (1)
- epigenetic (1)
- gastric cancer (1)
- hexahydropyrimidine (1)
- histamine (1)
- hydrogen bond (1)
- inflammation (1)
- inner membrane morphology (1)
- isomeric antagonists (1)
- kinetic resolution (1)
- kinetically trapped state (1)
- leukocyte-endothelial cell interaction (1)
- lipase (1)
- macromolecular crystallography (1)
- mechanochemical synthesis (1)
- membrane protein (1)
- membrane protein complex (1)
- menthol (1)
- mitochondria (1)
- molecular dynamics (1)
- molecular co-crystal (1)
- mouse (1)
- multi-drug-resistant pathogens (1)
- neuronal RNA (1)
- neurons (1)
- newly synthesized RNA (1)
- non-conventional hydrogen bonds (1)
- nuclear magnetic resonance (1)
- nuclear magnetic resonance (NMR) (1)
- oocytes (1)
- overview (1)
- p63 (1)
- particulate matter (1)
- phenolic resins (1)
- phenylsilane (1)
- photolabile Schutzgruppe (1)
- plant symbioses (1)
- plasmid copy number (1)
- polysilane (1)
- protein folding (1)
- quality control (1)
- quorum sensing (QS) (1)
- retrograde transport (1)
- rotary ATPase mechanism (1)
- silane (1)
- single molecule (1)
- single particle (1)
- single-particle tracking with photoactivated-localization microscopy (1)
- size of cigarettes (1)
- solid-state NMR spectroscopy (1)
- soluble epoxide hydrolase (1)
- spring-loaded activation (1)
- stereoselectivity (1)
- steroid (1)
- structural biolog (1)
- structural biology (1)
- superbugs (1)
- visualization of RNA (1)
- yeast (1)
- π–π stacking (1)
Institute
- Biochemie und Chemie (81)
- Biowissenschaften (9)
- Präsidium (9)
- Sonderforschungsbereiche / Forschungskollegs (8)
- Zentrum für Biomolekulare Magnetische Resonanz (BMRZ) (8)
- Exzellenzcluster Makromolekulare Komplexe (6)
- Medizin (6)
- Pharmazie (6)
- Center for Membrane Proteomics (CMP) (5)
- MPI für Biophysik (4)
Die NADPH-Oxidasen stellen eine wichtige Quelle für reaktive Sauerstoffspezies (Reactive oxygen species; ROS) im Organismus dar. Hierbei dienen die NADPH-Oxidasen nicht nur der Pathogenabwehr, sondern haben einen Einfluss auf eine Vielzahl an oxidativen, physiologischen Prozessen. Unter den NADPH-Oxidasen ist NOX4 einzigartig, da es hauptsächlich im endoplasmatischen Retikulum (ER) lokalisiert ist, konstitutiv aktiv ist und Wasserstoffperoxid (H2O2) produziert. Wir vermuten, dass diese besonderen Eigenschaften eine Konsequenz aus der Interaktion mit bislang unentdeckten NOX4-interagiereden Proteinen ist.
Zweidimensionale blau-native Polyacrylamid-Gelelektrophorese (BN-PAGE) kombiniert mit SDS-PAGE zeigte NOX4 in makromolekularen Komplexen. Interagierende Proteine wurden durch eine quantitative SILAC (stable isotope labeling of amino acids in cell culture)-Co-immunopräzipitation (Co-IP) in NOX4-überexprimierenden HEK293-Zellen gescreent. Hierdurch konnten verschiedene interagierende Proteine identifiziert werden, wobei Calnexin die robusteste Interaktion aufwies. Calnexin konnte zudem in NOX4-haltigen Komplexen durch Complexome Profiling der BN-PAGE oder gleichzeitiger Antikörperfärbung nachgewiesen werden. Die Calnexin-NOX4-Interaktion konnte mittels reverser Co-IP und Proximity ligation assay bestätigt werden, während NOX1, NOX2 und NOX5 nicht mit Calnexin interagierten. Calnexin-Defizienz, untersucht in embryonalen Mausfibroblasten oder durch shRNA gegen Calnexin, reduzierte die NOX4-Proteinexpression und ROS-Bildung, wobei die mRNA-Expression unverändert blieb. Des Weiteren wurde untersucht, ob der bekannte Interaktionspartner von NADPH-Oxidasen, p22phox, wirklich essentiell für die Expression oder Aktivität von NOX4 ist, da es nur in manchen der NOX4-Co-IPs nachgewiesen wurde. Um den Einfluss von p22phox für NOX4 aufzuklären wurde ein CRISPR/Cas9 Knockdown in NOX4-überexprimierenden HEK293 Zellen etabliert. p22phox zeigte keinen Einfluss auf die NOX4-Expression, jedoch war die NOX4-abhängige ROS-Produktion in p22phox-Knockout Zellen verschwunden.
Unsere Ergebnisse deuten darauf hin, dass endogenes NOX4 makromolekulare Komplexe mit Calnexin ausbildet, welches für die korrekte Reifung, Prozessierung und Funktion von NOX4 im ER nötig ist. Darüber hinaus ist p22phox nicht für die Reifung von NOX4, aber für dessen Aktivität nötig. Diese Ergebnisse zeigen eine vielfältige Regulation von NOX4 auf Proteinebene.
Cells perform a wide range of functions such as signalling, transportation, immunoprotection and metabolism. Unravelling the molecular mechanism behind those processes will provide a platform for more targeted and rational drug design. This is achieved by discerning the structural and functional aspects of the biological macromolecules involved. This thesis discusses about the biophysical characterization of protein structures and the biological importance of protein dynamics. Membrane receptors and enzymes which are ubiquitously present in our biological systems and regulate wide variety of functions are excellent choice for such study. From a pharmaceutical point of view, receptor and enzymes are exceptionally important drug targets as they represent the major share (receptor, 30% and enzymes, 47%) of all marketed drugs. Therefore, apart from biological insights, the detailed study of receptors and enzymes will provide the basis for new pharmaceutical applications. Most information about receptor activation and enzyme activity come from the structural and functional analysis of target members of the above mentioned systems.
In “Chapter 1 – General Introduction” the readers are introduced to the world of proteins with special focus on G-protein coupled receptors (GPCRs) and methyltransferases. The first part of this chapter discusses about GPCRs with emphasis on their classification, structural features and functions. GPCRs are the most abundant membrane receptors present in mammalian cells, accounting for almost 15% of all membrane proteins. The GPCR superfamily consists of ~800 members and can be subdivided into six classes (A-F). Class A containing rhodopsin, peptide hormones, olfactory GPCRs, is the most abundant with a large share of 85% of GPCR protein family. GPCRs share a common architecture of 7 transmembrane a-helices, with different ligand binding sites. Although a variety of ligands ranging from subatomic particles (a photon) to large proteins can activate a GPCR, their mechanism of signal transduction is almost similar. There are two major signal transduction pathways identified for GPCRs: the cAMP pathway and the phosphatidylinositol pathway. The therapeutic relevance of GPCRs has also been pointed out here since a large share (30%) of modern marketed drugs target GPCRs.
In the second part of this chapter, the structural and functional characterizations of methyltransferases (MTs) are discussed in detail. Several important biological processes in cells e.g. drug metabolism, gene transcription, epigenetic regulations are modulated by methylation of targets ranging from small biomolecules to large proteins. MTs are the proteins which catalyze this methylation reaction and transfer the methyl group to an acceptor molecule through SN2 like nucleophilic substitution reaction. The MTs can be classified on the basis of the substrate atoms they methylate: O (54% of all MTs), N (23%), C (18%), S (3%) and other acceptors (such as halides; 2%). They can also be categorized into five different classes (Class I-V) depending upon distinctive structural features facilitating substrate binding or catalytic activity. Rossmann fold and SET (acronym acquired from the Drosophila Su(var)3-9 and 'Enhancer of zeste' proteins) domain are the two characteristic structural motifs commonly found in MTs. Similar to GPCRs, MTs dysfunction has been shown to be involved in various diseases including neuropsychiatric diseases and cancer. Therefore they are also interesting targets for drug development. The final part of this chapter discusses the importance of structural biology in gathering information related to structure and conformational dynamics of proteins. The two prominent biophysical techniques used in structural biology, X-ray crystallography and NMR, are discussed with focus on their advantages and limitation. The importance of NMR spectroscopic techniques to investigate different dynamic processes of protein at atomic resolution under physiological conditions is also discussed. Real time NMR spectroscopy required for the analysis of slow protein dynamic processes (protein folding, enzyme catalysis, domain rearrangement) has been explained in detail.
The second part of the thesis (Chapters 3-4), which is the cumulative part, comprises the original publications grouped into 2 chapters according to their topic:
• NMR-spectroscopic characterization of the transiently populated photointermediates of bovine rhodopsin and it’s interaction with arrestin (Chapter 3)
• Structural and biophysical characterization of PaMTH1, a putative SAM dependent O-methyltransferase from filamentous fungi Podospora anserina (Chapter 4)
Each chapter is initiated by a detailed introduction to the topic, providing the framework for the following papers. The personal contribution of this thesis’ author to each publication is stated in the introduction to the respective article.
A growing body of evidence suggests that macrophage polarization dictates the expression of iron-regulated genes. Polarization towards iron sequestration depletes the microenvironment, whereby extracellular pathogen growth is limited and inflammation is fostered. In contrast, iron release contributes to cell proliferation, which is important for tissue regeneration. Moreover, macrophages constitute a major component of the infiltrates in most solid tumors. Considering the pivotal role of macrophages for iron homeostasis and their presence in association with poor clinical prognosis in tumors, we approached the possibility to target macrophages with intracellular iron chelators. Analyzing the expression of iron-regulated genes at mRNA and protein level in primary human macrophages, we found that the iron-release phenotype is a characteristic of polarized macrophages that, in turn, stimulate tumor cell growth and progression. The application of the intracellular iron chelator (TC3-S)2 shifted the macrophage phenotype from iron release towards sequestration, as determined by the iron-gene profile and atomic absorption spectroscopy (AAS). Moreover, whereas the addition of macrophage supernatants to tumor cells induced tumor growth and metastatic behavior, the supernatant of chelator-treated macrophages reversed this effect. Iron chelators demonstrated potent anti-neoplastic properties in a number of cancers, both in cell culture and in clinical trials. Our results suggest that iron chelation could affect not only cancer cells but also the tumor microenvironment by altering the iron-release phenotype of tumor-associated macrophages (TAMs). The study of iron chelators in conjunction with the effect of TAMs on tumor growth could lead to an improved understanding of the role of iron in cancer biology and to novel therapeutic avenues for iron chelation approaches.
An optochemokine tandem was developed to control the release of calcium from endosomes into the cytosol by light and to analyze the internalization kinetics of G-protein coupled receptors (GPCRs) by electrophysiology. A previously constructed rhodopsin tandem was re-engineered to combine the light-gated Ca2+-permeable cation channel Channelrhodopsin-2(L132C), CatCh, with the chemokine receptor CXCR4 in a functional tandem protein tCXCR4/CatCh. The GPCR was used as a shuttle protein to displace CatCh from the plasma membrane into intracellular areas. As shown by patch-clamp measurements and confocal laser scanning microscopy, heterologously expressed tCXCR4/CatCh was internalized via the endocytic SDF1/CXCR4 signaling pathway. The kinetics of internalization could be followed electrophysiologically via the amplitude of the CatCh signal. The light-induced release of Ca2+ by tandem endosomes into the cytosol via CatCh was visualized using the Ca2+-sensitive dyes rhod2 and rhod2-AM showing an increase of intracellular Ca2+ in response to light.
The P300/CBP-associated factor plays a central role in retroviral infection and cancer development, and the C-terminal bromodomain provides an opportunity for selective targeting. Here, we report several new classes of acetyl-lysine mimetic ligands ranging from mM to low micromolar affinity that were identified using fragment screening approaches. The binding modes of the most attractive fragments were determined using high resolution crystal structures providing chemical starting points and structural models for the development of potent and selective PCAF inhibitors.
Recently, two of the most common types of bone cancers in children and young adults have been proven to exhibit vulnerability to poly(ADP)-ribose polymerase, (PARP) inhibitors (e.g. olaparib, talazoparib). Ewing’s sarcoma (ES) are reported to harbor a fusion gene EWS-FLI1 (85%), inducing tumorigenesis. Additional, as the fusion gene acts as aberrant transcription factor, it similarly induces elevated PARP expression levels sensitizing ES to PARP inhibition. Second, by an exome sequencing approach in a set of primary osteosarcomas (OS) we identified mutation signatures being reminiscent of BRCA deficiency. Therefore, the sensitivity of a panel of OS cell lines to either talazoparib single treatment or in combination with several chemotherapeutic drugs was investigated.
To screen ES tumor cell lines against PARP inhibitors we applied four different PARP inhibitors (talazoparib, olaparib, niraparib and veliparib) that are frequently being used for clinical studies. We combined those PARP inhibitors with a set of chemotherapeutics (temozolomide (TMZ), SN-38, etoposide, ifosfamide, doxorubicin, vincristine and actinomycin D) that are part of the first-line therapy of ES patients. Here, we demonstrate how PARP inhibitors synergize with TMZ or SN-38 to induce apoptosis, whereas the combination of PARP inhibitors with the other drugs are not favorable. By investigation of key checkpoints in the molecular mechanisms of cell death, the pivotal role of the mitochondrial pathway of apoptosis mediating the synergy between olaparib and TMZ was revealed.
Employing talazoparib monotherapy in combination with or without several chemotherapeutic drugs (TMZ, SN-38, cisplatin, doxorubicin, methotrexate and etoposide/carboplatin), the correlation between homologous recombination (HR) repair deficiency (BRCAness) and the response to talazoparib as prototypical PARP inhibitor was validated in different OS cell lines. By calculation of combination indices (CI) and fraction affected (Fa) values, we identified TMZ as the most potent chemotherapeutic drug in combination with talazoparib inducing the mitochondrial apoptotic pathway in OS.
In our studies of two independent tumor entities with contrary genetic background we identified the combination of PARP inhibitor and TMZ as being most effective. Our studies point out that after TMZ induced DNA methylation and concomitant PARP trapping, DNA damage-imposed checkpoint kinase activation consequently induces G2-cell cycle arrest. Subsequent, PARP inhibitor/TMZ causes MCL-1 degradation, followed by activation of BAK and BAX, succeeding in loss of mitochondrial outer membrane potential (LMMP) and activation of downstream effector-caspases in mitochondrial apoptosis. Our findings emphasize the importance of PARP inhibition in order to chemosensitize ES, which express high PARP levels, or OS that bear features of BRCAness.
Weltweit sind ca. 130–180 Millionen Menschen mit HCV infiziert und jährlich sterben etwa 500.000 Menschen an dessen Folgen. Die neuartigen Therapien versprechen zwar eine sehr hohe Heilungsrate, sind aber aufgrund ihrer enorm hohen Kosten nur in Industrieländern verfügbar. Noch immer gibt es keine prophylaktische Vakzinierung gegen HCV. Deshalb ist es wichtig, den HCV-Lebenszyklus und die Interaktion zwischen Wirtszelle und Virus detailliert zu verstehen, um die Entwicklung von Therapien und Impfungen zu ermöglichen. Außerdem kann ein fundiertes Wissen von HCV translatiert werden und auf neuartige Erreger der Familie der Flaviviridae, wie Denguevirus und Zikavirus, angewendet werden. Während der Zelleintritt und die Replikation von HCV relativ gut charakterisiert sind, bleiben die Assemblierung und Freisetzung der viralen Partikel schlecht verstandene Schritte des HCV-Lebenszyklus. In dieser Arbeit sollte die Rolle des zellulären Proteins α-Taxilin im Lebenszyklus von HCV untersucht werden. In einer späteren Phase der Arbeit wurde der endosomale Freisetzungsweg von HCV untersucht. Dazu wurden HCV Varianten generiert und charakterisiert, die Fluoreszenz-Proteine im NS5A- und E1-Protein enthalten, durch die es möglich ist, den Replikationskomplex und die Viruspartikel zu visualisieren und zu quantifizieren und den viralen Lebenszyklus dadurch besser untersuchen zu können...